PCOS Treatment Options in 2025: Medications, Lifestyle, and More

PCOS in 2025: A More Nuanced Understanding

Polycystic ovary syndrome (PCOS) affects an estimated 8–13% of women of reproductive age, making it the most common hormonal disorder among women globally. Despite its name, you don't need polycystic ovaries to have PCOS — and the condition looks different in different women. In 2025, our understanding of PCOS has deepened considerably, and the treatment landscape has expanded beyond the oral contraceptive pill that was once the default recommendation for nearly every patient.

This guide covers the current evidence on PCOS management: from the medications showing real results to the lifestyle interventions with strong data, and the emerging options that may reshape care in coming years.

What Is PCOS? A Quick Refresher

PCOS is diagnosed using the Rotterdam criteria, which requires two of three features:

• Irregular or absent ovulation (irregular periods)
• Elevated androgens (high testosterone or DHEA-S on labs, or clinical signs like acne, excess hair growth)
• Polycystic ovary morphology on ultrasound (12+ follicles in an ovary or enlarged ovarian volume)

PCOS is not simply an ovarian problem — it's a systemic metabolic and endocrine condition. Most women with PCOS have some degree of insulin resistance, which drives elevated androgens via multiple mechanisms. This is why metabolic interventions are so central to treatment.

Medications for PCOS in 2025

Oral Contraceptive Pills (OCPs)

Combined OCPs remain widely used for managing menstrual irregularity, reducing androgen-driven symptoms (acne, hirsutism), and lowering ovarian cancer risk. They do not treat the underlying insulin resistance, however, and some women experience metabolic worsening on certain progestins. Provider guidance is important for selecting the right formulation.

Metformin

Metformin is an insulin-sensitizing medication originally developed for type 2 diabetes. It's now supported by strong evidence as a PCOS treatment — improving menstrual regularity, reducing androgens, supporting ovulation, and modestly improving metabolic markers. Current guidelines recommend metformin for women with PCOS and metabolic risk, and it can be used alongside OCPs or as an alternative for women who cannot or choose not to use hormonal contraception.

Inositol

Myo-inositol and D-chiro-inositol are naturally occurring insulin-sensitizing compounds with a growing evidence base in PCOS. A 40:1 ratio of myo-inositol to D-chiro-inositol has been shown to improve insulin sensitivity, menstrual regularity, and ovulatory function. While not FDA-approved as drugs, inositol supplements are considered safe and may be recommended as an adjunct by licensed providers.

GLP-1 Receptor Agonists (Semaglutide, Tirzepatide)

The emergence of highly effective GLP-1 and GIP/GLP-1 agonists has been a significant development for PCOS management. These medications reduce insulin resistance, promote weight loss, and directly lower androgen levels in women with PCOS. Studies published in 2023–2025 show semaglutide produces meaningful reductions in testosterone, improved menstrual regularity, and significant weight loss in women with PCOS — often outperforming metformin alone.

For women with PCOS and significant insulin resistance or obesity, a licensed provider may consider GLP-1 therapy as a powerful metabolic tool. Learn more in our article on semaglutide for women.

Spironolactone

Spironolactone is an androgen-blocking medication that can significantly reduce acne and unwanted hair growth (hirsutism) in women with PCOS. It's often prescribed alongside an OCP in women not seeking pregnancy, as it requires reliable contraception due to its potential effects on fetal development.

Clomiphene and Letrozole (for Fertility)

For women with PCOS who want to conceive, ovulation induction is a key goal. Letrozole has become the preferred first-line ovulation induction agent over clomiphene, with higher live birth rates in clinical trials. These medications require monitoring by a reproductive endocrinologist or OB-GYN.

Lifestyle Interventions: The Foundation of PCOS Management

Weight Loss (When Applicable)

For women with PCOS and excess body weight, even modest weight loss of 5–10% has been shown to restore menstrual regularity, lower androgens, and improve fertility in a significant proportion of women. Weight loss improves PCOS outcomes across almost every measured parameter. This makes it — along with the interventions that support it — central to care for many women.

Low-Glycemic Diet

A low-glycemic index diet reduces post-meal insulin spikes, directly addressing one of PCOS's root drivers. Research supports the Mediterranean diet, low-glycemic index diets, and reducing refined carbohydrates and added sugars for improving insulin sensitivity and hormonal balance in PCOS. Whole foods, lean proteins, fiber-rich vegetables, and healthy fats form the foundation.

Resistance Training

Muscle tissue is the primary site of glucose uptake, and building more of it improves insulin sensitivity independent of weight change. Resistance training 2–4 times weekly has demonstrated improvements in insulin resistance, testosterone levels, and quality of life in women with PCOS. Even modest increases in muscle mass can shift the metabolic picture meaningfully.

Sleep Optimization

Sleep disorders, including obstructive sleep apnea, are disproportionately common in women with PCOS. Poor sleep drives cortisol and insulin dysregulation. Prioritizing 7–9 hours of quality sleep is an underappreciated but evidence-based component of PCOS management.

Stress Reduction

Chronic stress elevates cortisol, which worsens insulin resistance and can suppress the HPG axis. Mind-body practices including yoga, mindfulness meditation, and cognitive behavioral therapy have shown promise in improving PCOS-related outcomes, particularly quality of life and hormonal parameters.

Mental Health and PCOS

Women with PCOS have significantly higher rates of anxiety, depression, and eating disorders than the general population. This bidirectional relationship — PCOS worsening mental health, and stress worsening PCOS — makes psychological support an important part of comprehensive care. Screening for depression and anxiety should be routine in PCOS management, and mental health support should be offered proactively rather than as an afterthought.

PCOS and Hair Loss

Androgenic alopecia — hair thinning driven by elevated androgens — is a common and distressing symptom of PCOS. Effective PCOS management (reducing androgens through metformin, GLP-1s, spironolactone, or OCPs) is often the most important step. For women dealing with PCOS-related hair loss, see our comprehensive guide to hair loss in women.

Monitoring Your PCOS

Women with PCOS should have regular monitoring of:

• Fasting glucose and insulin (or OGTT) to track insulin resistance
• HbA1c (to screen for prediabetes and diabetes)
• Lipid panel (PCOS is associated with dyslipidemia)
• Blood pressure
• Total and free testosterone, DHEA-S, SHBG
• Thyroid function (hypothyroidism is common and mimics PCOS symptoms)

Getting Comprehensive PCOS Care

Effective PCOS management requires a provider who understands both the hormonal and metabolic dimensions of the condition. Telehealth makes this expertise more accessible than ever. At Truventa Medical, licensed providers can evaluate your symptoms and labs, discuss your fertility goals, and create a personalized treatment plan that may include metabolic medications, hormonal therapy, lifestyle coaching, or a combination.

Summary

PCOS in 2025 is treated with a wider and more effective toolkit than ever before. From GLP-1 agonists and metformin to low-glycemic diets and targeted exercise, the evidence is clear: addressing insulin resistance is the cornerstone of PCOS management. With the right combination of medications, lifestyle changes, and monitoring, most women with PCOS can significantly reduce symptoms, restore hormonal balance, and improve their long-term metabolic health.